2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American …
Writing Committee Members, M Gulati, PD Levy… - Journal of the American …, 2021 - jacc.org
Aim This clinical practice guideline for the evaluation and diagnosis of chest pain provides
recommendations and algorithms for clinicians to assess and diagnose chest pain in adult …
recommendations and algorithms for clinicians to assess and diagnose chest pain in adult …
Diagnosing acute heart failure in the emergency department: a systematic review and meta‐analysis
JL Martindale, A Wakai, SP Collins… - Academic …, 2016 - Wiley Online Library
Background Acute heart failure (AHF) is one of the most common diagnoses assigned to
emergency department (ED) patients who are hospitalized. Despite its high prevalence in …
emergency department (ED) patients who are hospitalized. Despite its high prevalence in …
Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the …
With a prevalence of 5 800 000 (2% of the entire populace) in 2009 and an estimated yearly
incidence of 550 000, the burden of heart failure (HF) in the United States is tremendous. 1 …
incidence of 550 000, the burden of heart failure (HF) in the United States is tremendous. 1 …
Blood flow restriction training and the exercise pressor reflex: a call for concern
Blood flow restriction (BFR) training (also known as Kaatsu training) is an increasingly
common practice employed during resistance exercise by athletes attempting to enhance …
common practice employed during resistance exercise by athletes attempting to enhance …
[HTML][HTML] Effects of serelaxin in patients with acute heart failure
Background Serelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that
contributes to cardiovascular and renal adaptations during pregnancy. Previous studies …
contributes to cardiovascular and renal adaptations during pregnancy. Previous studies …
N-terminal pro–B-type natriuretic peptide in the emergency department: the ICON-RELOADED study
JL Januzzi, AA Chen-Tournoux, RH Christenson… - Journal of the American …, 2018 - jacc.org
Background: Contemporary reconsideration of diagnostic N-terminal pro–B-type natriuretic
peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed. Objectives: This …
peptide (NT-proBNP) cutoffs for diagnosis of heart failure (HF) is needed. Objectives: This …
[HTML][HTML] Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature
RR Ehrman, AN Sullivan, MJ Favot, RL Sherwin… - Critical Care, 2018 - Springer
Background Sepsis is a common condition encountered by emergency and critical care
physicians, with significant costs, both economic and human. Myocardial dysfunction in …
physicians, with significant costs, both economic and human. Myocardial dysfunction in …
Vitamin D deficiency and insufficiency among US adults: prevalence, predictors and clinical implications
X Liu, A Baylin, PD Levy - British Journal of Nutrition, 2018 - cambridge.org
Vitamin D deficiency (VDD) and insufficiency (VDI) are increasing at a global level, and they
are associated with increased risk of various diseases. However, little information is …
are associated with increased risk of various diseases. However, little information is …
Trends in the incidence of hypertensive emergencies in US emergency departments from 2006 to 2013
AT Janke, CD McNaughton, AM Brody… - Journal of the …, 2016 - Am Heart Assoc
Background The incidence of hypertensive emergency in US emergency departments (ED)
is not well established. Methods and Results This study is a descriptive epidemiological …
is not well established. Methods and Results This study is a descriptive epidemiological …
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial …
Aims Currently, no acute heart failure (AHF) therapy definitively improves outcomes.
Reducing morbidity and mortality from acute heart failure (AHF) remains an unmet need …
Reducing morbidity and mortality from acute heart failure (AHF) remains an unmet need …